Background An immune function assay shows promise for identifying solid organ recipients
at risk for infection or rejection. The following randomized prospective study was designed to …

Background. The Cylex ImmuKnow cell function assay (CICFA) is being considered as a
possible tool for identification of infection and rejection in transplant recipients. However, the …

BACKGROUND: Balancing immunosuppression to prevent rejection while minimizing
infection or drug toxicity risk is a major challenge in heart transplantation. Therapeutic drug …

A review of recent literature was performed to identify trends and evaluate outcomes with
respect to immunosuppression in pancreas transplantation (PTX). In the past decade, the …

Antibody induction and either tacrolimus/mycophenolate mofetil or tacrolimus/sirolimus
maintenance therapy with steroid withdrawal have become the mainstay of contemporary …

Background. Lung transplants, in particular, have the highest rate of infections among solid
organ transplant recipients. However, there is no existing objective measure to predict the …

In transplant recipients transplanted for hepatitis C, presentation of abnormal transaminases
can herald the presentation of recurrent hepatitis C, cellular rejection, or both. Given the …

Background. Common immunosuppression strategies after heart transplantation (HTx) are
based on accepted target drug levels, disregarding that drug levels do not correlate with the …

Background. New immunosuppression protocols have resulted in decreased rates of biopsy-
proven acute rejection; however, it is unclear whether recipients without biopsy-proven …

Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian
L, Lopez R, Zein N, Fung J. Measurement of CD4+ T‐cell function in predicting allograft …